FLONASE Nighttime Allergy Relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Triprolidine Hydrochloride.
Product ID | 0135-1329_070fb5a4-1848-41e8-90bf-57e682de1762 |
NDC | 0135-1329 |
Product Type | Human Otc Drug |
Proprietary Name | FLONASE Nighttime Allergy Relief |
Generic Name | Triprolidine Hcl |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-12-15 |
Marketing Category | OTC MONOGRAPH FINAL / |
Application Number | part341 |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Substance Name | TRIPROLIDINE HYDROCHLORIDE |
Active Ingredient Strength | 3 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-12-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FLONASE 97701366 not registered Live/Pending |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited 2022-12-02 |
FLONASE 97121742 not registered Live/Pending |
Glaxo Group Limited 2021-11-12 |
FLONASE 86746149 4959825 Live/Registered |
Glaxo Group Limited 2015-09-02 |
FLONASE 85958560 4809013 Live/Registered |
Glaxo Group Limited 2013-06-13 |
FLONASE 74389190 1870977 Live/Registered |
GLAXO GROUP LIMITED 1993-05-11 |
FLONASE 74109574 not registered Dead/Abandoned |
GLAXO GROUP LIMITED 1990-10-26 |